Adverse events should be reported. Reporting forms and information can be found at: yellowcard.mhra.gov.ukhttp://www.hpra.ie/homepage/about-us/report-an-issue Adverse events should also be reported to Fresenius Kabi Ltd. Cestrian Court, Eastgate Way, Manor Park, Runcorn, Cheshire, WA7 1NT. Tel +44 (0)1928 533 533
You are leaving the KabiCare website now. Please note that Fresenius Kabi have no affiliation or control over the content available on external third-party websites.
You are now leaving the KabiCare website and will be re-directed to your local Fresenius Kabi corporate website.
For general product information about IDACIO (adalimumab) for members of the public, please refer to the Patient Information Leaflet and the Summary of Product Characteristics(SmPC).
If you have any questions, please consult your healthcare professional team.